• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于区分肺癌与良性肺部疾病及健康人的呼吸分析中靶向与非靶向方法的比较

Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons.

作者信息

Koureas Michalis, Kalompatsios Dimitrios, Amoutzias Grigoris D, Hadjichristodoulou Christos, Gourgoulianis Konstantinos, Tsakalof Andreas

机构信息

Department of Hygiene and Epidemiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 22 Papakyriazi Street, 41222 Larissa, Greece.

Bioinformatics Laboratory, Department of Biochemistry and Biotechnology, University of Thessaly, 41500 Larissa, Greece.

出版信息

Molecules. 2021 Apr 29;26(9):2609. doi: 10.3390/molecules26092609.

DOI:10.3390/molecules26092609
PMID:33946997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8125376/
Abstract

The aim of the present study was to compare the efficiency of targeted and untargeted breath analysis in the discrimination of lung cancer (Ca+) patients from healthy people (HC) and patients with benign pulmonary diseases (Ca-). Exhaled breath samples from 49 Ca+ patients, 36 Ca- patients and 52 healthy controls (HC) were analyzed by an SPME-GC-MS method. Untargeted treatment of the acquired data was performed with the use of the web-based platform XCMS Online combined with manual reprocessing of raw chromatographic data. Machine learning methods were applied to estimate the efficiency of breath analysis in the classification of the participants. Results: Untargeted analysis revealed 29 informative VOCs, from which 17 were identified by mass spectra and retention time/retention index evaluation. The untargeted analysis yielded slightly better results in discriminating Ca+ patients from HC (accuracy: 91.0%, AUC: 0.96 and accuracy 89.1%, AUC: 0.97 for untargeted and targeted analysis, respectively) but significantly improved the efficiency of discrimination between Ca+ and Ca- patients, increasing the accuracy of the classification from 52.9 to 75.3% and the AUC from 0.55 to 0.82. Conclusions: The untargeted breath analysis through the inclusion and utilization of newly identified compounds that were not considered in targeted analysis allowed the discrimination of the Ca+ from Ca- patients, which was not achieved by the targeted approach.

摘要

本研究的目的是比较靶向呼气分析和非靶向呼气分析在区分肺癌(Ca+)患者与健康人(HC)以及良性肺部疾病患者(Ca-)方面的效率。采用固相微萃取-气相色谱-质谱联用(SPME-GC-MS)方法分析了49例Ca+患者、36例Ca-患者和52例健康对照(HC)的呼出气体样本。利用基于网络的XCMS Online平台对采集的数据进行非靶向处理,并结合对原始色谱数据的人工再处理。应用机器学习方法评估呼气分析在参与者分类中的效率。结果:非靶向分析揭示了29种信息性挥发性有机化合物(VOC),其中17种通过质谱和保留时间/保留指数评估得以鉴定。在区分Ca+患者与HC方面,非靶向分析的结果略好(准确性:91.0%,曲线下面积[AUC]:0.96;靶向分析的准确性为89.1%,AUC为0.97),但显著提高了区分Ca+和Ca-患者的效率,将分类准确性从52.9%提高到75.3%,AUC从0.55提高到0.82。结论:通过纳入和利用靶向分析中未考虑的新鉴定化合物进行非靶向呼气分析,能够区分Ca+和Ca-患者,而靶向方法无法做到这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e155/8125376/4a7f7680f0a5/molecules-26-02609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e155/8125376/3cc5d39e8f92/molecules-26-02609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e155/8125376/4a7f7680f0a5/molecules-26-02609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e155/8125376/3cc5d39e8f92/molecules-26-02609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e155/8125376/4a7f7680f0a5/molecules-26-02609-g002.jpg

相似文献

1
Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons.用于区分肺癌与良性肺部疾病及健康人的呼吸分析中靶向与非靶向方法的比较
Molecules. 2021 Apr 29;26(9):2609. doi: 10.3390/molecules26092609.
2
Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.良性肺部疾病对选择挥发性有机化合物作为肺癌标志物的混杂影响。
J Breath Res. 2018 Sep 14;12(4):046013. doi: 10.1088/1752-7163/aad9cc.
3
The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.分析呼气、组织和细胞系中肺癌的挥发性有机化合物生物标志物。
Cancer Biomark. 2012;11(4):129-37. doi: 10.3233/CBM-2012-00270.
4
Volatolomics analysis of exhaled breath and gastric-endoluminal gas for distinguishing early upper gastrointestinal cancer from benign.呼出气挥发性代谢组学分析与胃腔内气体分析用于鉴别早期上消化道癌与良性疾病
J Breath Res. 2023 May 3;17(3). doi: 10.1088/1752-7163/accfb8.
5
Study of confounding factors influence on lung cancer diagnostics effectiveness using gas chromatography-mass spectrometry analysis of exhaled breath.应用呼出气气相色谱-质谱分析研究混杂因素对肺癌诊断效果的影响。
Biomark Med. 2021 Aug;15(11):821-829. doi: 10.2217/bmm-2020-0828. Epub 2021 Jul 5.
6
Breath carbonyl compounds as biomarkers of lung cancer.呼气羰基化合物作为肺癌的生物标志物。
Lung Cancer. 2015 Oct;90(1):92-7. doi: 10.1016/j.lungcan.2015.07.005. Epub 2015 Jul 19.
7
Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma.呼出气挥发性有机化合物:准确区分肺腺癌和肺鳞癌的有前途的方法。
J Breath Res. 2024 Aug 5;18(4). doi: 10.1088/1752-7163/ad6474.
8
Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.用于肺癌筛查和早期检测的呼出气体中挥发性有机化合物(VOCs)的计算指标。
Lung Cancer. 2021 Apr;154:197-205. doi: 10.1016/j.lungcan.2021.02.006. Epub 2021 Feb 14.
9
Noninvasive detection of lung cancer by analysis of exhaled breath.通过分析呼气检测肺癌。
BMC Cancer. 2009 Sep 29;9:348. doi: 10.1186/1471-2407-9-348.
10
Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.吸烟与呼出气中代谢挥发性有机化合物的关联。
Int J Mol Sci. 2017 Oct 25;18(11):2235. doi: 10.3390/ijms18112235.

引用本文的文献

1
Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework.使用机器学习确定肺癌呼出气体生物标志物——一种新的分析框架。
Sci Rep. 2025 Jul 18;15(1):26085. doi: 10.1038/s41598-025-11365-4.
2
Collection methods of exhaled volatile organic compounds for lung cancer screening and diagnosis: a systematic review.用于肺癌筛查和诊断的呼出挥发性有机化合物收集方法:一项系统综述
J Thorac Dis. 2024 Nov 30;16(11):7978-7998. doi: 10.21037/jtd-24-1001. Epub 2024 Nov 29.
3
GC-MS-based metabolomics of volatile organic compounds in exhaled breath: applications in health and disease. A review.

本文引用的文献

1
Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD.呼出气中的挥发性有机化合物作为肺癌、哮喘和慢性阻塞性肺疾病的生物标志物
J Clin Med. 2020 Dec 24;10(1):32. doi: 10.3390/jcm10010032.
2
Bridging Targeted and Untargeted Mass Spectrometry-Based Metabolomics via Hybrid Approaches.通过混合方法桥接基于靶向和非靶向质谱的代谢组学
Metabolites. 2020 Aug 27;10(9):348. doi: 10.3390/metabo10090348.
3
Target Analysis of Volatile Organic Compounds in Exhaled Breath for Lung Cancer Discrimination from Other Pulmonary Diseases and Healthy Persons.
基于气相色谱-质谱联用技术的呼出气中挥发性有机化合物代谢组学:在健康与疾病中的应用。综述
Front Mol Biosci. 2024 Jan 8;10:1295955. doi: 10.3389/fmolb.2023.1295955. eCollection 2023.
4
Identification of urinary volatile organic compounds as a potential non-invasive biomarker for esophageal cancer.鉴定尿液中的挥发性有机化合物作为食管癌潜在的非侵入性生物标志物。
Sci Rep. 2023 Oct 30;13(1):18587. doi: 10.1038/s41598-023-45989-1.
5
Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules.肺结节良恶性评估的生物标志物研究进展。
Chest. 2023 Oct;164(4):1028-1041. doi: 10.1016/j.chest.2023.05.025. Epub 2023 May 25.
6
Experiences and Perspectives of GC-MS Application for the Search of Low Molecular Weight Discriminants of Schizophrenia.GC-MS 应用于寻找精神分裂症低分子量标志物的经验和观点。
Molecules. 2022 Dec 31;28(1):324. doi: 10.3390/molecules28010324.
7
A Panel of Bile Volatile Organic Compounds Servers as a Potential Diagnostic Biomarker for Gallbladder Cancer.一组胆汁挥发性有机化合物可作为胆囊癌的潜在诊断生物标志物。
Front Oncol. 2022 Mar 30;12:858639. doi: 10.3389/fonc.2022.858639. eCollection 2022.
8
Analyses of lung cancer-derived volatiles in exhaled breath and models.分析肺癌患者呼气挥发性成分及模型。
Exp Biol Med (Maywood). 2022 Jul;247(13):1179-1190. doi: 10.1177/15353702221082634. Epub 2022 Apr 11.
9
pyAIR-A New Software Tool for Breathomics Applications-Searching for Markers in TD-GC-HRMS Analysis.pyAIR:用于呼吸组学应用的新软件工具——在 TD-GC-HRMS 分析中寻找标志物。
Molecules. 2022 Mar 23;27(7):2063. doi: 10.3390/molecules27072063.
10
Breath Analysis: A Promising Tool for Disease Diagnosis-The Role of Sensors.呼吸分析:疾病诊断的有前途工具-传感器的作用。
Sensors (Basel). 2022 Feb 6;22(3):1238. doi: 10.3390/s22031238.
呼出气体中挥发性有机化合物用于鉴别肺癌与其他肺部疾病及健康人的目标分析
Metabolites. 2020 Aug 3;10(8):317. doi: 10.3390/metabo10080317.
4
Inter-laboratory reproducibility of an untargeted metabolomics GC-MS assay for analysis of human plasma.用于分析人血浆的非靶向代谢组学 GC-MS 分析的实验室间重现性。
Sci Rep. 2020 Jul 2;10(1):10918. doi: 10.1038/s41598-020-67939-x.
5
Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.用于早期检测恶性胸膜间皮瘤的呼吸分析:挥发性有机化合物(VOCs)的测定及可能的生化途径
Cancers (Basel). 2020 May 16;12(5):1262. doi: 10.3390/cancers12051262.
6
Recent advances in breath analysis to track human health by new enrichment technologies.近年来,通过新的富集技术,呼吸分析在追踪人类健康方面取得了新的进展。
J Sep Sci. 2020 Jan;43(1):226-240. doi: 10.1002/jssc.201900769. Epub 2019 Dec 19.
7
Searching for selected VOCs in human breath samples as potential markers of lung cancer.在人类呼气样本中寻找选定的挥发性有机化合物作为肺癌的潜在标志物。
Lung Cancer. 2019 Sep;135:123-129. doi: 10.1016/j.lungcan.2019.02.012. Epub 2019 Feb 15.
8
Sensors for detecting pulmonary diseases from exhaled breath.用于从呼气中检测肺部疾病的传感器。
Eur Respir Rev. 2019 Jun 26;28(152). doi: 10.1183/16000617.0011-2019. Print 2019 Jun 30.
9
Targeted breath analysis: exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes.靶向呼吸分析:外源性挥发性有机化合物 (EVOC) 作为代谢途径特异性探针。
J Breath Res. 2019 May 17;13(3):032001. doi: 10.1088/1752-7163/ab1789.
10
Multimodal chemometric approach for the analysis of human exhaled breath in lung cancer patients by TD-GC × GC-TOFMS.通过 TD-GC×GC-TOFMS 分析肺癌患者呼出气的多模式化学计量学方法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 1;1114-1115:146-153. doi: 10.1016/j.jchromb.2019.01.029. Epub 2019 Jan 31.